4.7 Article

Tcf-1 protects anti-tumor TCR-engineered CD8+ T-cells from GzmB mediated self-destruction

Related references

Note: Only part of the references are listed.
Article Immunology

Ectopic Tcf1 expression instills a stem-like program in exhausted CD8+ T cells to enhance viral and tumor immunity

Qiang Shan et al.

Summary: The study demonstrates that ectopic Tcf1 expression promotes the generation of stem cell-like Tex cells in chronic viral infection and tumor models, enhancing their functionality and response to checkpoint blockade. This highlights the therapeutic potential of harnessing Tcf1-enforced transcriptional programs for viral and tumor control.

CELLULAR & MOLECULAR IMMUNOLOGY (2021)

Article Cell Biology

FOXO1 constrains activation and regulates senescence in CD8 T cells

Arnaud Delpoux et al.

Summary: This study demonstrates the crucial role of FOXO1 in maintaining cellular vitality and response to antigenic stress in T cells. Different cellular age states may lead to alterations in levels of FOXO1, TCF7, and AP-1 factors. These characteristics are also associated with the formation of T cells with features of cellular senescence.

CELL REPORTS (2021)

Article Hematology

Regnase-1 suppresses TCF-1+ precursor exhausted T-cell formation to limit CAR-T-cell responses against ALL

Wenting Zheng et al.

Summary: This study demonstrates that the deficiency of Regnase-1 enhances CAR-T cell expansion and memory-like cell formation, leading to improved tumor clearance and sustained remission. Regnase-1 deficiency also reduces exhaustion and enhances the activity of CAR-T cells.

BLOOD (2021)

Article Oncology

Integrative Bulk and Single-Cell Profiling of Premanufacture T-cell Populations Reveals Factors Mediating Long-Term Persistence of CAR T-cell Therapy

Gregory M. Chen et al.

Summary: The study revealed that chronic IFN signaling regulated by IRF7 is associated with poor CAR T-cell persistence, while the TCF7 regulon is maintained in effector T cells among patients with long-term CAR T-cell persistence. These findings offer key insights into the molecular determinants of clinical CAR T-cell function.

CANCER DISCOVERY (2021)

Article Multidisciplinary Sciences

An engineered IL-2 partial agonist promotes CD8+ T cell stemness

Fei Mo et al.

Summary: Adoptive transfer of antigen-specific T cells is a significant advancement in cancer immunotherapy, and maintaining a stem-cell-like state before transfer is beneficial for therapeutic efficacy.

NATURE (2021)

Article Multidisciplinary Sciences

Phenotype, specificity and avidity of antitumour CD8+ T cells in melanoma

Giacomo Oliveira et al.

Summary: The authors demonstrate through single-cell profiling and T cell receptor specificity screening that tumour antigen recognition influences the phenotypes of CD8(+) T cells and antitumour immune responses. Non-tumour-reactive T cells show a non-exhausted memory phenotype, while melanoma-reactive lymphocytes exhibit an exhausted state, providing insights into the properties of the anti-melanoma TCR repertoire.

NATURE (2021)

Article Oncology

Δ133p53α enhances metabolic and cellular fitness of TCR-engineered T cells and promotes superior antitumor immunity

Kevin Jan Legscha et al.

Summary: This study revealed a broad effect of the Delta 133p53 alpha isoform in regulating T lymphocyte function. Enhancing the fitness and effector functions of senescent T cells by modulating p53 isoforms could be utilized for future translational research to improve cancer immunotherapy and immunosenescence-related diseases.

JOURNAL FOR IMMUNOTHERAPY OF CANCER (2021)

Article Immunology

Sestrins induce natural killer function in senescent-like CD8+ T cells

Branca Pereira et al.

NATURE IMMUNOLOGY (2020)

Article Multidisciplinary Sciences

Selective targeting of engineered T cells using orthogonal IL-2 cytokine-receptor complexes

Jonathan T. Sockolosky et al.

SCIENCE (2018)

Article Biochemistry & Molecular Biology

Interleukin-2 shapes the cytotoxic T cell proteome and immune environment-sensing programs

Christina M. Rollings et al.

SCIENCE SIGNALING (2018)

Article Biochemistry & Molecular Biology

Interleukin-2 shapes the cytotoxic T cell proteome and immune environment-sensing programs

Christina M. Rollings et al.

SCIENCE SIGNALING (2018)

Article Hematology

TCF1 expression marks self-renewing human CD8+ T cells

Radomir Kratchmarov et al.

BLOOD ADVANCES (2018)

Article Biochemistry & Molecular Biology

The granzyme B-Serpinb9 axis controls the fate of lymphocytes after lysosomal stress

C. H. Bird et al.

CELL DEATH AND DIFFERENTIATION (2014)

Article Immunology

Granzyme B-Mediated Damage of CD8+ T Cells Impairs Graft-versus-Tumor Effect

Guanglin Bian et al.

JOURNAL OF IMMUNOLOGY (2013)

Review Oncology

Paths to stemness: building the ultimate antitumour T cell

Luca Gattinoni et al.

NATURE REVIEWS CANCER (2012)

Article Oncology

Determinants of Successful CD8+ T-Cell Adoptive Immunotherapy for Large Established Tumors in Mice

Christopher A. Klebanoff et al.

CLINICAL CANCER RESEARCH (2011)

Article Biochemistry & Molecular Biology

A human memory T cell subset with stem cell-like properties

Luca Gattinoni et al.

NATURE MEDICINE (2011)

Article Biochemistry & Molecular Biology

A new β-catenin-dependent activation domain in T cell factor

FA Atcha et al.

JOURNAL OF BIOLOGICAL CHEMISTRY (2003)

Article Biochemistry & Molecular Biology

Granzyme B-mediated apoptosis proceeds predominantly through a Bcl-2-inhibitable mitochondrial pathway

MJ Pinkoski et al.

JOURNAL OF BIOLOGICAL CHEMISTRY (2001)